Why the study?
Over 74 million people worldwide suffer from valvular heart ailments, warranting an overview of valve biology, clinical disease, and emerging therapeutic approaches.
Answers are grounded in this paper and cite their sources.
This review provides a comprehensive overview of valvular heart diseases, including emerging transcatheter therapies, stem cell approaches, and the role of AI and computational models.
Heart valves maintain the unidirectional blood flow ensuring effective cardiac functioning.Currently, over 74 million people worldwide suffer from valvular heart ailments such as regurgitation and stenosis.This review focuses on the structures and mechanisms of the four major valves, aortic, mitral, tricuspid, and pulmonary valves comprehending the biology and clinical aspects of both congenital and acquired valvular diseases.This manuscript reviews emerging updates in transcatheter mitral valve repair, transcatheter aortic valve replacement, and stem cells based approaches for the management of various valvular diseases.Additionally, the article provides insights into computational models and artificial intelligence in next generation valvular therapies.
No takes yet. Share an insight, caveat, or question.
Jiayin Li (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: